Kissick Family Foundation FTD Grant Program, 2026–2027
The Kissick Family Foundation is offering grants for research on frontotemporal dementia (FTD) to accelerate basic discoveries and improve patient outcomes. Researchers studying the fundamental biology of sporadic FTD are encouraged to apply. Applicants must submit a letter of intent by November 4, 2026, with full proposals invited afterward. Funding provides up to $500,000 over two years, including indirect costs.
Eligibility: Researchers studying frontotemporal dementia, particularly the fundamental biology of sporadic forms, are eligible to apply.
Pipeline
Funder track record · does Kissick Family Foundation actually pay grants?
✅ Proven payer · 16 grantees found · last payout 2026-10-08 · checked 2026-11-03 · 0 forum reports, 10 web pages read, 3 unverifiable claims dropped
Proven payer: at least 3 named grantees and one payout in the last 90 days. Every grantee below is quoted word for word from its source. When a source does not date a grant, the date is when that page or post was published.
| Grantee | Amount | Date | Evidence |
|---|---|---|---|
| Michael Guo, MD, PhD, Michael Haney, PhD, and Hong Xu, PhD | — | 2026-10-08 | “The Penn team — consisting of three IOA Members, Michael Guo, MD, PhD, Michael Haney, PhD, and Hong Xu, PhD — will receive funding for their project "Decoding somatic genome instability as a driver of selective neuronal ” source |
| William W. Seeley and Alex Pollen | — | 2026-09-24 page date | “At the University of California, San Francisco, William W. Seeley and Alex Pollen will study neuron-specific vulnerability and the biological processes involved in FTLD-TDP, a major form of frontotemporal degeneration.” source |
| Michael Guo, Michael Haney and Hong Xu | — | 2026-09-24 page date | “Michael Guo, Michael Haney and Hong Xu at the University of Pennsylvania will investigate how instability in the genomes of individual cells may contribute to the selective loss of neurons seen in FTD.” source |
| William W. Seeley, MD, and Alex Pollen, PhD, at the University of California, San Francisco | — | 2026-09-24 | “William W. Seeley, MD, and Alex Pollen, PhD, at the University of California, San Francisco are probing neuron type-specific vulnerability to reveal upstream FTLD-TDP disease mechanisms” source |
| Clotilde Lagier-Tourenne, MD, PhD, and Liron Bar-Peled, PhD, at Massachusetts General Hospital and Harvard Medical School | — | 2026-09-24 | “Clotilde Lagier-Tourenne, MD, PhD, and Liron Bar-Peled, PhD, at Massachusetts General Hospital and Harvard Medical School are building a chemical proteomics-based "DrugMap" spanning FTD subtypes” source |
| Jochen Weishaupt, MD, at Ulm University, working with collaborators at INSERM and the German Cancer Research Center | — | 2026-09-24 | “Jochen Weishaupt, MD, at Ulm University, working with collaborators at INSERM and the German Cancer Research Center, is investigating genetic mosaicism in FTD pathogenesis” source |
| Michael Guo, MD, PhD, at the University of Pennsylvania | — | 2026-09-24 | “Michael Guo, MD, PhD, at the University of Pennsylvania rounds out the group, leading a team decoding somatic genome instability as a driver of selective neuronal vulnerability in FTD” source |
| 10000 Brains Neuro AL Inc | $1.0M | 2026-03-03 page date | “The largest 2024 recipient was 10000 Brains Neuro AL Inc ($1.0M).” source |
| Ule Jernej, PhD, UK Dementia Research Institute, Kings College London, England, UK | — | 2025-09-15 | “Co-Investigator: Ule Jernej, PhD, UK Dementia Research Institute, Kings College London, England, UK” source |
| Beyond Memory | — | 2024-10-08 page date | “Beyond Memory is a dementia awareness campaign that shines a light on less common types of dementia - including frontotemporal, Lewy body, and vascular dementia.” source |
| The Association for Frontotemporal Degeneration (AFTD) | — | 2024-10-08 page date | “The Association for Frontotemporal Degeneration (AFTD) is the leading organization focused exclusively on the spectrum of FTD disorders.” source |
| UnRavelled | — | 2024-10-08 page date | “UnRavelled is an award-winning play based on the extraordinary lives of Anne Adams, a brilliant scientist turned painter, and Maurice Ravel, composer of the iconic Boléro. Both were affected by Frontotemporal Dementia (F” source |
| Barmada Lab | — | 2024-10-08 page date | “The Barmada Lab investigates the foundations of RNA and protein homeostasis in neurons, and how disruptions in these processes lead to neurodegenerative conditions.” source |
| Kampmann Lab | — | 2024-10-08 page date | “The Kampmann Lab, led by Dr. Martin Kampmann, develops and applies innovative technologies to understand cellular and molecular mechanisms of aging-associated neurodegenerative diseases, and to discover new therapeutic s” source |
| GENFI | — | 2024-10-08 page date | “Note: The Kissick Family Foundation's grant to GENFI is administered by its strategic partner, the Milken Institute.” source |
| Lewy Body Dementia Association | — | 2024-10-08 page date | “The Lewy Body Dementia Association (LBDA) is working to change that. As the leading national organization dedicated to improving the lives of individuals and families affected by Lewy body dementia (LBD)” source |
Trust breakdown (4/4 checkable facts verified)
| Signal | Weight | Result | Note |
|---|---|---|---|
| deadline | 0.35 | 100% | quoted in source |
| amount | 0.25 | 100% | figure appears in source |
| apply link | 0.075 | 100% | link in source |
| funder | 0.075 | 100% | named in source |
| source quality | 0.15 | 50% | social or search hit |
| model confidence | 0.1 | 90% | model self-report |
Fit breakdown (against the ORG_* profile)
| Signal | Weight | Result | Note |
|---|---|---|---|
| model fit | 0.5 | 10% | model rated 10% |
| ecosystem overlap | 0.25 | 0% | none vs aleo |
| category overlap | 0.15 | 0% | research vs zk, privacy, infra, dev_tooling, security, interoperability |
| tech overlap | 0.1 | 0% | none vs rust, leo, zk |
Sources (1)
| Role | Document | From | Fetched |
|---|---|---|---|
| primary | Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session | Milken Institute | Web discovery: RFP and grant searches | 2026-09-29 |
History (1)
| v | Changed | Fields |
|---|---|---|
| 1 | 2026-09-29 | created |
Extracted text
Webinar
# Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session
24 Sep 2026
Topics
[Philanthropy](/topics/philanthropy)
[Grant Management](/taxonomy/philanthropy/grant-management)
[Medical Philanthropy](/topics/philanthropy/medical-philanthropy)
[Medical Research Funding](/topics/philanthropy/medical-philanthropy/medical-research-funding)
[Health](/topics/health)
[Neurological Health](/topics/health/neurological-health)
SHARE
* [](<http://www.linkedin.com/shareArticle?mini=true&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session&source=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session> "Linkedin")
* [](https://twitter.com/intent/tweet?url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&hashtags=Hashtag "Twitter")
* [](<https://www.facebook.com/share.php?u=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session> "Facebook")
[The Kissick Family Foundation](https://kissickfamilyfoundation.org/) [Frontotemporal Dementia (FTD) Grant Program](https://sciencephilanthropy.org/focus-areas/brain-disorders/frontotemporal-dementia/kissick-family-foundation/), in partnership with the Milken Institute [Science Philanthropy Accelerator for Research and Collaboration](https://sciencephilanthropy.org/), is accepting letters of intent now through **Wednesday, November 4, 2026**, for its fourth round of funding. Funded projects will be eligible for up to $500,000 over two years, inclusive of indirect costs.
The grant program aims to accelerate basic discoveries, introduce novel research approaches, and, ultimately, improve patient outcomes for people living with FTD. A broad range of topics is responsive to this call.
An informal informational webinar for interested applicants will be held on **Tuesday, October 13, 2026**, at 11 a.m. US Eastern Time (8 a.m. Pacific Time; 5 p.m. Central European Time). [Attendees must register using this Zoom registration link](https://milkeninstitute-org.zoom.us/meeting/register/pkUaoNaURZujsWbcjIQ-uQ).
The recorded webinar will be hosted on this page after its conclusion.
Interested applicants should apply for the grant program’s fourth round of funding by submitting a letter of intent by November 4, 2026, at 11:59 p.m. US Eastern Time. Please see the full [2026–2027 Request for Proposals](https://sciencephilanthropy.org/funding/requests-for-proposals/) for additional information.
SHARE
* [](<http://www.linkedin.com/shareArticle?mini=true&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session&source=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session> "Linkedin")
* [](https://twitter.com/intent/tweet?url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&hashtags=Hashtag "Twitter")
* [](<https://www.facebook.com/share.php?u=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session> "Facebook")
## Related Content
* 
[RFPs](/content-hub/rfps)
## [Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program (2026–2027)](/content-hub/rfps/request-proposals-kissick-family-foundation-frontotemporal-dementia-grant-program-2026-2027)
24 Sep 2026
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund the fourth annual cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
[Read Article](/content-hub/rfps/request-proposals-kissick-family-foundation-frontotemporal-dementia-grant-program-2026-2027)
* 
[Report](/content-hub/research-and-reports/reports)
## [The Global Brain Care Coalition: A Model to Put Brain Science into Action](/content-hub/research-and-reports/reports/global-brain-care-coalition-model-put-brain-science-action)
27 Aug 2026
It takes an average of 17 years for a scientific discovery to travel from the lab to clinical practice. In brain health, that delay has a real cost as the global population ages and more people face conditions such as dementia, stroke, and...
[Read Report](/content-hub/research-and-reports/reports/global-brain-care-coalition-model-put-brain-science-action)
   
[Samantha Schumm, PhD,](/experts/samantha-schumm-phd) [Lillian Parr,](/experts/lillian-parr) [Agnes Stephens,](/experts/agnes-stephens) and [Sylvie Raver, PhD](/experts/sylvie-raver-phd)
27 Aug 2026
* [Webinar](/content-hub/podcasts-webinars/webinars)
## [Ann Theodore Foundation Breakthrough Sarcoidosis Initiative, 2025–2026: Information Session](/content-hub/webinars/ann-theodore-foundation-breakthrough-sarcoidosis-initiative-2025-2026-information-session)
22 Oct 2025
The Ann Theodore Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is accepting optional letters of intent through Thursday October 23, 2025, for its fifth round of...
[View Webinar](/content-hub/webinars/ann-theodore-foundation-breakthrough-sarcoidosis-initiative-2025-2026-information-session)
* 
[RFPs](/content-hub/rfps)
## [Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial](/content-hub/rfps/request-proposals-ann-theodore-foundation-sarcoidosis-inhibitor-mtor-sim-trial)
20 Feb 2026
The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...
[Read Article](/content-hub/rfps/request-proposals-ann-theodore-foundation-sarcoidosis-inhibitor-mtor-sim-trial)
* 
[News Release](/content-hub/news-releases)
## [Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment](/content-hub/news-releases/milken-institute-ann-theodore-foundation-launch-new-grant-support-clinical-trial-potential)
20 Feb 2026
February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...
[Read Article](/content-hub/news-releases/milken-institute-ann-theodore-foundation-launch-new-grant-support-clinical-trial-potential)
* 
[Report](/content-hub/research-and-reports/reports)
## [Uterine Leiomyosarcoma: A Giving Smarter Guide](/content-hub/research-and-reports/reports/uterine-leiomyosarcoma-giving-smarter-guide)
24 Jun 2025
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...
[Read Report](/content-hub/research-and-reports/reports/uterine-leiomyosarcoma-giving-smarter-guide)
IM  
[Ishtiaq Mawla,](/experts/ishtiaq-mawla) [Caitlyn Barrett, PhD,](/experts/caitlyn-barrett-phd) and [Cara Altimus, PhD](/staff/cara-altimus-phd)
24 Jun 2025
* 
[RFPs](/content-hub/rfps)
## [Request for Proposals: Misophonia](/content-hub/rfps/request-proposals-misophonia)
10 Dec 2021
The Misophonia Research Fund is pleased to release the 2023 Request for Proposals. The General Grant Program RFP is soliciting research proposals that aim to characterize misophonia, develop objective methods to assess misophonia, or...
[Read Article](/content-hub/rfps/request-proposals-misophonia)
* 
[Report](/content-hub/research-and-reports/reports)
## [Misophonia - A Giving Smarter Guide](/content-hub/research-and-reports/reports/misophonia-giving-smarter-guide)
11 Oct 2020
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...
[Read Report](/content-hub/research-and-reports/reports/misophonia-giving-smarter-guide)
JR 
James A. Randall and [Cara Altimus, PhD](/staff/cara-altimus-phd)
11 Oct 2020
* 
[Report](/content-hub/research-and-reports/reports)
## [Anxiety: A Giving Smarter Guide](/content-hub/research-and-reports/reports/anxiety-giving-smarter-guide)
3 May 2026
Anxiety is a natural and adaptive emotion that promotes vigilance against potential threats. However, anxiety that persists or is disproportionate to actual risk becomes dysfunctional and can impair daily functioning.
[Read Report](/content-hub/research-and-reports/reports/anxiety-giving-smarter-guide)
IM   
[Ishtiaq Mawla,](/experts/ishtiaq-mawla) [Alison Huang, PhD,](/staff/alison-huang-phd) [Lillian Parr,](/experts/lillian-parr) and [Sylvie Raver, PhD](/experts/sylvie-raver-phd)
3 May 2026